These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 29625193)
21. Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor. He J; Wang Y; Duan F; Jiang H; Chen MF; Tang SY Planta Med; 2010 Nov; 76(16):1834-9. PubMed ID: 20560114 [TBL] [Abstract][Full Text] [Related]
22. Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway. Meng Y; Lin ZM; Ge N; Zhang DL; Huang J; Kong F Am J Chin Med; 2015; 43(7):1471-86. PubMed ID: 26503559 [TBL] [Abstract][Full Text] [Related]
23. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway. Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice. Dai C; Zhang B; Liu X; Ma S; Yang Y; Yao Y; Feng M; Bao X; Li G; Wang J; Guo K; Ma W; Xing B; Lian W; Xiao J; Cai F; Zhang H; Wang R Endocrinology; 2013 Mar; 154(3):1247-59. PubMed ID: 23384836 [TBL] [Abstract][Full Text] [Related]
25. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227 [TBL] [Abstract][Full Text] [Related]
26. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway. Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676 [TBL] [Abstract][Full Text] [Related]
27. Oridonin Suppresses Proliferation of Human Ovarian Cancer Cells via Blockage of mTOR Signaling. Xia R; Chen SX; Qin Q; Chen Y; Zhang WW; Zhu RR; Deng AM Asian Pac J Cancer Prev; 2016; 17(2):667-71. PubMed ID: 26925661 [TBL] [Abstract][Full Text] [Related]
28. Anticancer agent icaritin induces apoptosis through caspase-dependent pathways in human hepatocellular carcinoma cells. Sun L; Peng Q; Qu L; Gong L; Si J Mol Med Rep; 2015 Apr; 11(4):3094-100. PubMed ID: 25434584 [TBL] [Abstract][Full Text] [Related]
29. Icariin inhibits autophagy and promotes apoptosis in SKVCR cells through mTOR signal pathway. Jiang S; Chang H; Deng S; Fan D Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):4-10. PubMed ID: 29808793 [TBL] [Abstract][Full Text] [Related]
30. Anticancer effects of Ixeris dentata (Thunb. ex Thunb.) nakai extract on human melanoma cells A375P and A375SM. Lee HN; Shin SA; Choo GS; Kim HJ; Park YS; Park BK; Kim BS; Kim SK; Cho SD; Nam JS; Choi CS; Jung JY J Ethnopharmacol; 2016 Dec; 194():1022-1031. PubMed ID: 27836777 [TBL] [Abstract][Full Text] [Related]
31. Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells. Ke F; Wang Z; Song X; Ma Q; Hu Y; Jiang L; Zhang Y; Liu Y; Zhang Y; Gong W Drug Des Devel Ther; 2017; 11():1753-1766. PubMed ID: 28670110 [TBL] [Abstract][Full Text] [Related]
32. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells. Guo Y; Zhang X; Meng J; Wang ZY Eur J Pharmacol; 2011 May; 658(2-3):114-22. PubMed ID: 21376032 [TBL] [Abstract][Full Text] [Related]
33. Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo. Chang KY; Tsai SY; Wu CM; Yen CJ; Chuang BF; Chang JY Clin Cancer Res; 2011 Nov; 17(22):7116-26. PubMed ID: 21976531 [TBL] [Abstract][Full Text] [Related]
34. Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells. Pal HC; Baxter RD; Hunt KM; Agarwal J; Elmets CA; Athar M; Afaq F Oncotarget; 2015 Sep; 6(29):28296-311. PubMed ID: 26299806 [TBL] [Abstract][Full Text] [Related]
35. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Asselin E; Mills GB; Tsang BK Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739 [TBL] [Abstract][Full Text] [Related]
36. Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway. Wang P; Hu Y; Qu P; Zhao Y; Liu J; Zhao J; Kong B Bioengineered; 2022 Jan; 13(1):1931-1941. PubMed ID: 35001804 [TBL] [Abstract][Full Text] [Related]
37. Combination of metformin and RG7388 enhances inhibition of growth and induction of apoptosis of ovarian cancer cells through the PI3K/AKT/mTOR pathway. Cui Y; Zhou J; Rong F Biochem Biophys Res Commun; 2020 Dec; 533(4):665-671. PubMed ID: 33051060 [TBL] [Abstract][Full Text] [Related]
38. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
39. The role of PI3K/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment. Gedaly R; Angulo P; Chen C; Creasy KT; Spear BT; Hundley J; Daily MF; Shah M; Evers BM Anticancer Res; 2012 Jul; 32(7):2531-6. PubMed ID: 22753710 [TBL] [Abstract][Full Text] [Related]
40. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells. Hu JL; Hu XL; Guo AY; Wang CJ; Wen YY; Cang SD Oncotarget; 2017 Jul; 8(30):49380-49394. PubMed ID: 28537902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]